We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$99.1B
AUM Growth
+$7.92B
Cap. Flow
+$3.27B
Cap. Flow %
3.3%
Top 10 Hldgs %
23.39%
Holding
4,186
New
432
Increased
2,037
Reduced
1,399
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 14%
2 Financials 8.86%
3 Healthcare 8.09%
4 Industrials 6.83%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOMO icon
3201
Domo
DOMO
$187M
$380K ﹤0.01%
6,751
+936
+16% +$60.8K
NWN icon
3202
Northwest Natural Holdings
NWN
$2.14B
$380K ﹤0.01%
7,050
+2,589
+58% +$124K
MORF
3203
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$380K ﹤0.01%
6,004
-813
-12% -$37.3K
JYNT icon
3204
The Joint Corp
JYNT
$119M
$379K ﹤0.01%
+7,827
New +$293K
SYNA icon
3205
Synaptics
SYNA
$4.2B
$379K ﹤0.01%
+2,800
New +$341K
HYLN icon
3206
Hyliion Holdings
HYLN
$734M
$377K ﹤0.01%
35,327
-61,808
-64% -$968K
WIP icon
3207
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
$377K ﹤0.01%
6,793
+1,009
+17% +$57.8K
FHLC icon
3208
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
$376K ﹤0.01%
+6,374
New +$377K
KTF
3209
DWS Municipal Income Trust
KTF
$352M
$376K ﹤0.01%
32,301
-69,551
-68% -$803K
MRVI icon
3210
Maravai LifeSciences
MRVI
$861M
$376K ﹤0.01%
+10,550
New +$350K
PDN icon
3211
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$367M
$376K ﹤0.01%
10,271
-2,835
-22% -$102K
VERI icon
3212
Veritone
VERI
$139M
$376K ﹤0.01%
+15,690
New +$560K
ASXC
3213
DELISTED
Asensus Surgical, Inc.
ASXC
$375K ﹤0.01%
115,500
+45,145
+64% +$164K
FRO icon
3214
Frontline
FRO
$9.02B
$374K ﹤0.01%
51,047
PIO icon
3215
Invesco Global Water ETF
PIO
$278M
$373K ﹤0.01%
10,303
-589
-5% -$21K
FBGX
3216
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
$372K ﹤0.01%
662
AOK icon
3217
iShares Core Conservative Allocation ETF
AOK
$795M
$371K ﹤0.01%
9,598
-1,033
-10% -$40.1K
RRR icon
3218
Red Rock Resorts
RRR
$3.67B
$371K ﹤0.01%
11,387
-621
-5% -$18K
SHO icon
3219
Sunstone Hotel Investors
SHO
$2.02B
$371K ﹤0.01%
29,743
-3,461
-10% -$41.3K
CROX icon
3220
Crocs
CROX
$6.36B
$370K ﹤0.01%
+4,602
New +$351K
HD icon
3221
CALL
Home Depot
HD
$341B
$370K ﹤0.01%
33,700
+800
+2% +$221K
TRIL
3222
DELISTED
Trillium Therapeutics Inc.
TRIL
$370K ﹤0.01%
34,482
+20,885
+154% +$258K
ATRO icon
3223
Astronics
ATRO
$4.57B
$369K ﹤0.01%
24,539
-1,227
-5% -$15.9K
NUMV icon
3224
Nuveen ESG Mid-Cap Value ETF
NUMV
$461M
$369K ﹤0.01%
10,724
+1,820
+20% +$59.4K
NEV
3225
DELISTED
NUVEEN ENHANCED MUNICIPAL VALUE FUND
NEV
$369K ﹤0.01%
21,974

Similar funds

Raymond James & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Raymond James & Associates held 4,186 positions worth $99.1B, up 8.7% from $91.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates deployed $3.27B of net new capital in Q1 2021, opening 432 new positions and adding to 2,037 existing holdings. Its largest new stake was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard High Dividend Yield ETF, an estimated $671M trimmed.

  • Raymond James & Associates's largest Q1 2021 buy was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2021, an estimated $1.36B increase.
  • Raymond James & Associates's biggest Q1 2021 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $671M.
  • Raymond James & Associates fully exited Sensient Technologies in Q1 2021, selling an estimated $15.6M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $99.1B portfolio in Q1 2021.
  • Raymond James & Associates opened 432 new positions and closed 199 in Q1 2021.
  • Raymond James & Associates's portfolio value rose 8.7% quarter-over-quarter to $99.1B.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.